Can a common gout drug slow heart disease in people with a gene variant?
NCT ID NCT07362966
First seen Jan 24, 2026 · Last updated May 19, 2026 · Updated 17 times
Summary
This study tests whether colchicine, a drug used for gout, can slow the buildup of plaque in heart arteries. It includes 120 adults aged 40-85 who recently had a heart attack and have a specific gene variant (TET2-CHIP). Researchers will measure plaque changes using CT scans over time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
General Hospital of Northern Theater Command
Shenyang, Liaoning, China
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.